Chen Amy Y, Schrag Nicole, Hao Yongping, Flanders W Dana, Kepner James, Stewart Andrew, Ward Elizabeth
Department of Otolaryngology, Emory University School of Medicine, and Department of Health Services Research, American Cancer Society, Atlanta, Georgia 30329, USA.
Otolaryngol Head Neck Surg. 2006 Dec;135(6):831-7. doi: 10.1016/j.otohns.2006.07.012.
In 1991, a randomized study was published and demonstrated that use of nonsurgical therapy (chemoradiation) provided similar survival to total laryngectomy (the gold standard) for patients with advanced-stage laryngeal cancer. The purpose of this study was to assess how treatment of advanced laryngeal cancer was influenced by such developments in non-surgical therapy.
Patterns of care study using National Cancer Database (1985-2001).
The percentage of advanced-stage patients treated with chemoradiation increased from 8.3% to 20.8% while the proportion treated with radiation alone decreased from 38.9% to 23.0%. Use of chemoradiation increased at a significantly faster rate after the 1991 publication at both community cancer centers and teaching research facilities. The use of total laryngectomy decreased slightly during this period.
The use of chemoradiation increased after the 1991 publication. It was impossible to determine from the NCDB whether additional patients who could benefit from chemo-RT were not offered or did not complete this treatment option. We recommend that treatment recommendations discussed at tumor boards be recorded in cancer registries.
1991年发表了一项随机研究,结果表明,对于晚期喉癌患者,采用非手术治疗(放化疗)与全喉切除术(金标准)的生存率相似。本研究的目的是评估非手术治疗的这些进展如何影响晚期喉癌的治疗。
利用国家癌症数据库(1985 - 2001年)进行的医疗模式研究。
接受放化疗的晚期患者比例从8.3%增至20.8%,而单纯接受放疗的比例从38.9%降至23.0%。1991年发表该研究后,社区癌症中心和教学研究机构接受放化疗的患者比例显著加快增长。在此期间,全喉切除术的使用率略有下降。
1991年发表该研究后,放化疗的使用有所增加。无法从国家癌症数据库确定是否有其他可从放化疗中获益的患者未得到这种治疗或未完成该治疗方案。我们建议将肿瘤委员会讨论的治疗建议记录在癌症登记处。